Send to

Choose Destination
Balkan Med J. 2016 Nov;33(6):688-690. Epub 2016 Nov 1.

Acute Eosinophilic Pneumonia with Respiratory Failure Induced by Synthetic Cannabinoid Inhalation.

Author information

Department of Chest Diseases, Gülhane Training and Research Hospital, Ankara, Turkey.
Department of Pathology, Gülhane Training and Research Hospital, Ankara, Turkey.



In recent days, synthetic cannabinoid derivatives have become life threatening for young people. Here, we want to share a case of acute eosinophilic pneumonia triggered by inhalation of synthetic cannabinoid, new side effects of which are being detected day by day.


A 21-year-old male, who had no history of pulmonary diseases, was admitted to the clinic with shortness of breath. His oxygen saturation was measured as 85-86% in room air. Common irregular ground-glass opacities were observed in thorax radiology. His peripheral blood eosinophil count was 1100 cell/mm3 with a leukocyte differential of 12%. Sputum eosinophilia was also observed. The patient was diagnosed with acute eosinophilic pneumonia in terms of current clinical, radiological and laboratory findings. Rapid remission was achieved with corticosteroid therapy.


This is the first reported case of acute eosinophilic pneumonia induced by synthetic cannabinoid inhalation.


Acute eosinophilic pneumonia; sputum eosinophilia; synthetic cannabinoid

Supplemental Content

Full text links

Icon for Galenos Yayinevi Icon for PubMed Central
Loading ...
Support Center